Neuraminidase Inhibitor class drugs

10 results
Alembic Pharmaceuticals Inc.
Usage: Oseltamivir phosphate is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older within 48 hours of symptom onset. It is also used for prophylaxis in individuals 1 year and older. Vaccination is recommended annually and resistance may impact effectiveness.
Cadila Healthcare Limited
Novadoz Pharmaceuticals LLC
Usage: Oseltamivir phosphate capsules are indicated for the treatment of influenza A and B in patients aged 2 weeks and older, symptomatic for no more than 48 hours, and for prophylaxis in patients 1 year and older. It is not a substitute for annual influenza vaccination.
A-S Medication Solutions
Usage: Oseltamivir phosphate capsules are indicated for treating acute uncomplicated influenza A and B in patients aged 2 weeks and older within 48 hours of symptom onset. They are also used for prophylaxis of influenza in patients aged 1 year and older. It's not a substitute for vaccination.
Zydus Lifesciences Limited
Novadoz Pharmaceuticals LLC
Usage: Oseltamivir phosphate for oral suspension is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older with symptoms for no more than 48 hours, and for prophylaxis in patients aged 1 year and older. It is not a substitute for vaccination.
Proficient Rx LP
Usage: Oseltamivir phosphate capsules are indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older, symptomatic for no more than 48 hours. They are also used for influenza prophylaxis in patients aged 1 year and older. Not a substitute for vaccination.
Aurobindo Pharma Limited
Usage: Oseltamivir phosphate oral suspension is indicated for treating acute, uncomplicated influenza A and B in patients aged 2 weeks and older within 48 hours of symptoms onset, and for prophylaxis in patients 1 year and older. It is not a substitute for vaccination and may have limitations due to resistance.
AvKARE
Usage: Oseltamivir phosphate capsules are indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older, symptomatic for no more than 48 hours, and for prophylaxis in patients aged 1 year and older. It is not a substitute for vaccination.
Alvogen Inc.
Usage: Oseltamivir phosphate for oral suspension is indicated for the treatment of influenza in patients who have been symptomatic for no more than two days. It is not a substitute for annual influenza vaccination and is contraindicated in patients with end-stage renal disease not undergoing dialysis.